Sign In
Buy GSK
$50.67
-1.48 (-2.84%)
At Close: Jun 18, 2026
GSK Sales, Profit Rise on Boost from Cancer Drugs
02:27am, Wednesday, 30'th Apr 2025
The British pharmaceutical giant said that its first-quarter sales rose to 7.52 billion pounds from 7.36 billion pounds the year prior.
British drugmaker GSK says 'well positioned' to absorb tariff hit
02:10am, Wednesday, 30'th Apr 2025
British drugmaker GSK said on Wednesday it was "well positioned" to respond to any potential financial impact from sector-specific tariffs if they were implemented and it had identified options within
Pharma firms maastraz
12:06pm, Tuesday, 29'th Apr 2025
Jimmy Muchechetere, senior equity analyst at Investec, weighs in on the prospect of pharmaceutical tariffs and recent U.S. investment commitments from the sector.
GSK to Report First-Quarter Earnings: Is a Beat in Store?
10:15am, Monday, 28'th Apr 2025
We expect GSK's specialty products like Cabenuva, Juluca, Dovato, Nucala, Ojjaara, Jemperli and Trelegy Ellipta to have driven first-quarter sales performance.
GSK update brings US vaccine exposure into spotlight, as sceptic RFK Jr looms
06:16am, Friday, 25'th Apr 2025
First-quarter results from GSK PLC (LSE:GSK, NYSE:GSK) will focus on commentary around the outlook, including interpretation of US policy changes under vaccine sceptic health secretary Robert Kennedy
Analysts Estimate GSK (GSK) to Report a Decline in Earnings: What to Look Out for
11:07am, Wednesday, 23'rd Apr 2025
Glaxo (GSK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Eli Lilly, Vertex, AbbVie and More Pharma Stocks to Own as Tariffs Loom
11:13am, Tuesday, 22'nd Apr 2025
Trump's tariff policy is the latest uncertainty to plague the pharmaceutical sector.
LLY, NVO and AMGN Forecast – Pharma Stocks to Open Mixed
09:00am, Monday, 21'st Apr 2025
The three pharma stocks in this analysis all look a bit mixed in the premarket, after seeing some momentum late last week. This is especially true with LLY, as you will see on the charts.
UK approves combination therapies of GSK's blood cancer drug Blenrep
11:46am, Thursday, 17'th Apr 2025
GSK said on Thursday two combination therapies with its cancer drug, Blenrep, have received approval from British authorities for the treatment of a type of blood cancer in adults who had received at
Here's Why GSK (GSK) is a Strong Value Stock
10:40am, Thursday, 17'th Apr 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
GSK's Pentavalent Meningococcal Jab Recommended for Use by ACIP
10:20am, Thursday, 17'th Apr 2025
The U.S. CDC's Advisory Committee recommends the use of GSK's pentavalent Penmenvy vaccine as part of the adolescent meningococcal vaccination schedule.
GSK & PFE's RSV Vaccines Recommended for Use in Adults Aged 50-59
10:20am, Thursday, 17'th Apr 2025
The U.S. CDC's Advisory Committee recommends the use of GSK and Pfizer's RSV vaccines in adults aged 50-59 who are at high risk of severe RSV disease.
--76-week trial is evaluating the safety and efficacy of a progranulin-elevating candidate in slowing disease progression-- --Enrollment completed ahead of schedule-- SOUTH SAN FRANCISCO, Calif., Apri
PHILADELPHIA--(BUSINESS WIRE)-- #Arexvy--AREXVY recommended for adults aged 50-59 at increased risk for severe RSV disease by US Advisory Committee on Immunization Practices.
GSK's 5-in-1 Meningococcal Vaccine PENMENVY Receives Positive Recommendation from US Advisory Committee on Immunization Practices
04:57pm, Wednesday, 16'th Apr 2025
PHILADELPHIA--(BUSINESS WIRE)-- #Adolescents--GSK's 5-in-1 meningococcal vaccine PENMENVY receives positive recommendation from US Advisory Committee on Immunization Practices.
